X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1004) 1004
Book Chapter (195) 195
Newspaper Article (18) 18
Book / eBook (5) 5
Patent (4) 4
Book Review (2) 2
Magazine Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Publication (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (442) 442
life sciences & biomedicine (431) 431
humans (388) 388
male (312) 312
oncology (261) 261
prostate cancer (197) 197
aged (171) 171
middle aged (167) 167
cancer (121) 121
adult (106) 106
metastasis (97) 97
treatment outcome (96) 96
female (93) 93
antineoplastic agents - therapeutic use (87) 87
urology & nephrology (83) 83
prostatic neoplasms, castration-resistant - drug therapy (82) 82
care and treatment (81) 81
neoplasms - drug therapy (80) 80
prostatic neoplasms - pathology (80) 80
aged, 80 and over (75) 75
prostatic neoplasms - drug therapy (70) 70
prostatic neoplasms, castration-resistant - pathology (66) 66
research (60) 60
clinical trials (59) 59
neoplasm metastasis (59) 59
prognosis (59) 59
antineoplastic combined chemotherapy protocols - therapeutic use (55) 55
urology (55) 55
chemotherapy (53) 53
animals (49) 49
tumors (49) 49
analysis (47) 47
disease progression (46) 46
metastases (46) 46
prostate (45) 45
prostate-specific antigen - blood (42) 42
medical research (41) 41
abridged index medicus (40) 40
mutation (40) 40
patients (38) 38
pharmacology & pharmacy (38) 38
castration (37) 37
kaplan-meier estimate (37) 37
prostatic neoplasms - genetics (37) 37
drug therapy (36) 36
maximum tolerated dose (36) 36
phenylthiohydantoin - analogs & derivatives (36) 36
castration-resistant prostate cancer (35) 35
disease-free survival (35) 35
hematology, oncology and palliative medicine (35) 35
neoplasm staging (35) 35
genetic aspects (33) 33
neoplasms - genetics (33) 33
androgens (32) 32
antineoplastic combined chemotherapy protocols - adverse effects (32) 32
cancer therapies (32) 32
neoplasms - pathology (32) 32
prostatic neoplasms, castration-resistant - blood (32) 32
retrospective studies (32) 32
abiraterone acetate (31) 31
antineoplastic agents - adverse effects (31) 31
cell line, tumor (31) 31
general & internal medicine (31) 31
medicine, general & internal (31) 31
antineoplastic agents - pharmacology (30) 30
dna repair (30) 30
dose-response relationship, drug (30) 30
androgen antagonists - therapeutic use (29) 29
drug resistance, neoplasm (29) 29
biomarkers (28) 28
double-blind method (28) 28
drug administration schedule (28) 28
health aspects (28) 28
prostatic neoplasms, castration-resistant - mortality (28) 28
abiraterone (27) 27
docetaxel (27) 27
time factors (27) 27
antineoplastic agents - administration & dosage (26) 26
prostatic neoplasms - metabolism (26) 26
taxoids - administration & dosage (26) 26
clinical trials as topic (25) 25
oncology, experimental (25) 25
orchiectomy (25) 25
survival (25) 25
survival analysis (25) 25
risk factors (24) 24
androstenes (23) 23
cell biology (23) 23
mice (23) 23
signal transduction - drug effects (23) 23
taxoids - therapeutic use (23) 23
cancer research (22) 22
neoplastic cells, circulating - pathology (22) 22
prednisone - administration & dosage (22) 22
prostatic neoplasms, castration-resistant - genetics (22) 22
receptors, androgen - metabolism (22) 22
signal transduction (22) 22
antineoplastic agents - pharmacokinetics (21) 21
antineoplastic agents, hormonal - therapeutic use (21) 21
cabazitaxel (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1126) 1126
Spanish (82) 82
Portuguese (20) 20
Dutch (15) 15
Latin (4) 4
Danish (3) 3
French (3) 3
German (3) 3
Norwegian (2) 2
Swedish (2) 2
Icelandic (1) 1
Italian (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European urology, ISSN 0302-2838, 2016, Volume 71, Issue 1, pp. e9 - e10
...We read with interest the article by de Bono et al [1] reporting on the efficacy of subsequent chemotherapy in men with metastatic castration-resistant... 
Urology | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Care and treatment | Chemotherapy | Analysis | Metastasis | Acetates | Prostate cancer | Cancer | Index Medicus
Journal Article
Future oncology (London, England), ISSN 1479-6694, 11/2012, Volume 8, Issue 11, pp. 1381 - 1382
Johann de Bono speaks to Francesca Lake, Commissioning Editor. Johann de Bono leads the prostate cancer team at the Institute of Cancer Research (London, UK... 
Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2015, Volume 373, Issue 18, pp. 1697 - 1708
Journal Article
The New England journal of medicine, ISSN 1533-4406, 07/2014, Volume 371, Issue 5, pp. 424 - 433
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2018, Volume 378, Issue 7, pp. 645 - 657
Interventions added to androgen-deprivation therapy in men with metastatic prostate cancer have recently been noted to increase survival. Decisions about which... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antigens | Androgens | Clinical trials | Biomarkers | Metastasis | Cancer therapies | Prostate cancer | Prostate | Metastases | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2019, Volume 381, Issue 26, pp. 2506 - 2518
Journal Article
Journal Article